| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/08/2013 | US20130202573 Thioacetate compounds, compositions and methods of use |
| 08/08/2013 | US20130200359 Triphenylene-based materials for organic electroluminescent devices |
| 08/07/2013 | EP2623493A1 N-(hetero)aryl,2-(hetero)aryl-substituted acetamides for use as WNT signaling modulators |
| 08/07/2013 | EP2621921A1 Solid state forms of a potent hcv inhibitor |
| 08/07/2013 | EP2621920A1 Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals |
| 08/07/2013 | EP2621919A1 Phenylquinazoline derivatives |
| 08/07/2013 | EP2621918A1 Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors |
| 08/07/2013 | EP2621913A1 Substituted benzimidazole and imidazopyridine compounds useful as cyp17 modulators |
| 08/07/2013 | EP2621275A1 Aryl-substituted imidazoles |
| 08/07/2013 | CN103237801A Quinoline or quinazoline derivatives with apoptosis inducing activity on cells |
| 08/07/2013 | CN103237798A Substituted benzimidazole and imidazopyridine compounds used as CYP17 modulators |
| 08/07/2013 | CN103237794A P2X4 receptor antagonist |
| 08/07/2013 | CN103232843A Electroluminescent material and application thereof |
| 08/07/2013 | CN103232443A Indazole derivative crystal and its preparation method and use |
| 08/07/2013 | CN103232442A Monohydrate crystal form, pharmaceutical composition and application thereof, and preparation technology |
| 08/07/2013 | CN103232441A Pyrilamine compounds with herbicidal activity and application thereof |
| 08/07/2013 | CN101622234B Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions |
| 08/07/2013 | CN101212969B Azinone and diazinone V3 inhibitors for depression and stress disorders |
| 08/06/2013 | US8501956 Benzimidazole compounds |
| 08/06/2013 | US8501945 Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate and its purification for use as pharmaceutically active compound |
| 08/06/2013 | US8501757 Substituted phenylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same |
| 08/06/2013 | US8501747 Functionally selective alpha2C adrenoreceptor agonists |
| 08/06/2013 | US8501745 Piperazine PDE4 inhibitors and uses thereof |
| 08/06/2013 | US8501740 Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors |
| 08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/06/2013 | US8501731 Derivatives of 6[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one having antitumor activity |
| 08/06/2013 | US8501166 Pyrimidinyl indole compounds |
| 08/06/2013 | CA2654945C Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
| 08/06/2013 | CA2588513C 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 08/06/2013 | CA2586271C Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors |
| 08/06/2013 | CA2567513C Histamine h3 receptor agents, preparation and therapeutic uses |
| 08/06/2013 | CA2529949C Antiviral compounds and methods |
| 08/01/2013 | WO2013112878A1 Mcl-1 modulating compositions |
| 08/01/2013 | WO2013111831A1 Pyrrole compound |
| 08/01/2013 | WO2013111108A1 5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors |
| 08/01/2013 | WO2013110622A1 Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines |
| 08/01/2013 | WO2013110433A1 Azaheterocyclic compounds |
| 08/01/2013 | WO2013110134A1 Heterocyclic compounds and methods for their use |
| 08/01/2013 | WO2013085339A3 Organic light-emitting compound and organic electroluminescent device using same |
| 08/01/2013 | WO2012061248A8 Novel specific hcv ns3 protease inhibitors |
| 08/01/2013 | WO2012006474A3 Compounds and methods for inhibiting phosphate transport |
| 08/01/2013 | US20130197242 Process for the preparation of crystalline form ii of l-malic acid salt of sunitinib |
| 08/01/2013 | US20130197217 1, 2, 4-triazolone derivative |
| 08/01/2013 | US20130197059 Integrin antagonist conjugates for targeted delivery to cells expressing lfa-1 |
| 08/01/2013 | US20130197011 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
| 08/01/2013 | US20130197009 Antagonist for mutant androgen receptor |
| 08/01/2013 | US20130196990 Benzimidazole Derivatives As PI3 Kinase Inhibitors |
| 08/01/2013 | US20130196985 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 08/01/2013 | US20130196971 Fatty acid synthase inhibitors |
| 08/01/2013 | US20130196967 Heterocyclic compounds as inhibitors of leukotriene production |
| 08/01/2013 | US20130196952 Heterocyclic derivatives for the treatment of diseases |
| 08/01/2013 | US20130194693 Magnetic media and magnetic recording devices using fluorine compounds |
| 07/31/2013 | EP2620435A1 Phenyl and benzodioxinyl substituted indazole derivatives |
| 07/31/2013 | EP2620432A2 Diarylhydantoin compounds |
| 07/31/2013 | EP2619195A1 Hepatitis c virus inhibitors |
| 07/31/2013 | EP2619185A1 Matrix metalloproteinase inhibitors |
| 07/31/2013 | CN103228661A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/31/2013 | CN103228649A Quinazoline carboxamide azetidines |
| 07/31/2013 | CN103228648A Crystalline forms of (s)-2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl) propanoic acid |
| 07/31/2013 | CN103228647A Materials for organic electroluminescent devices |
| 07/31/2013 | CN103228646A Pyrimidine compound and use for pest control thereof |
| 07/31/2013 | CN103228634A Matrix metalloproteinase inhibitors |
| 07/31/2013 | CN103228629A Substituted cyclopentyl -azines as CaSR- active compounds |
| 07/31/2013 | CN103228141A Substituted fused pyrimidinones and dihydropyrimidinones |
| 07/31/2013 | CN103224488A 杂环化合物或其盐 Heterocyclic compound or a salt thereof |
| 07/31/2013 | CN101899038B Near-infrared light emitting ionic complex and preparation method thereof |
| 07/31/2013 | CN101775011B N-substituted phenyl-3-methylene heterocyclic arene-2,5-dimethylpyrrole compound and application thereof in anti-HIV/AIDS |
| 07/31/2013 | CN101072758B 喹唑啉衍生物 Quinazoline derivatives |
| 07/30/2013 | US8497296 N,N′-hydrazino-bis-isatin derivatives with selective activity against multidrug-resistant cancer cells |
| 07/30/2013 | US8497289 3.1.0 bicyclic GlyT1 inhibitors and methods of making and using same |
| 07/30/2013 | US8497278 Imidazo[1,2-a]pyridine compounds |
| 07/30/2013 | CA2659549C Compositions and methods relating to novel compounds and targets thereof |
| 07/30/2013 | CA2599538C N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 07/30/2013 | CA2590811C Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 07/30/2013 | CA2561305C Tetrahydro-indazole cannabinoid modulators |
| 07/30/2013 | CA2547410C 1,2,3-triazole amide derivatives as inhibitors of cytokie production |
| 07/30/2013 | CA2531856C Benzimidazole carboxamides as raf kinase inhibitors |
| 07/25/2013 | WO2013109882A1 Substituted pyrimidine compounds and their use as syk inhibitors |
| 07/25/2013 | WO2013109859A1 Dye compositions, methods of preparation, conjugates thereof, and methods of use |
| 07/25/2013 | WO2013109045A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/25/2013 | WO2013109011A1 Novel cyanine derivatives having meso-reactive functional group at polymethine chain and preparation method thereof |
| 07/25/2013 | WO2013108800A1 Substituted phenylazole derivative |
| 07/25/2013 | WO2013108754A1 Pyrazine carboxamide compound |
| 07/25/2013 | WO2013107820A1 Novel fap inhibitors |
| 07/25/2013 | WO2013107761A1 Substituted triazoles and their use for treatment and/or prevention neurological and psychiatric disorders |
| 07/25/2013 | WO2013107333A1 Piperazinyl pyrimidine derivatives, preparation method and use thereof |
| 07/25/2013 | US20130190512 Processes for the preparation of 3-(pyrrol-2-yl)methylene)-2-pyrrolones using 2-silyloxy-pyrroles |
| 07/25/2013 | US20130190355 Dual inhibitors of farnesyltransferase and geranylgeranyltransferase i |
| 07/25/2013 | US20130190339 Pro-Neurogenic Compounds |
| 07/25/2013 | US20130190330 Bisaryl-bonded aryltriazolones and use thereof |
| 07/25/2013 | US20130190320 Heterocyclic compounds and uses as anticancer agents |
| 07/25/2013 | US20130190311 Pyridazinone derivatives |
| 07/25/2013 | US20130190309 Phthalazinone and related analogs as sirtuin modulators |
| 07/25/2013 | US20130190302 Modulators of amyloid beta |
| 07/25/2013 | US20130190300 Compositions and methods for inhibiting the proliferation of cells |
| 07/25/2013 | US20130190298 Substituted pyridazine carboxamide compounds |
| 07/25/2013 | US20130190296 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 07/25/2013 | US20130190284 X-Ray and Gamma-Photon Activable Organic Compounds, Their Preparation and Their Uses |
| 07/25/2013 | US20130190273 Methods for Treating Amyotrophic Lateral Sclerosis Using Pro-Neurogenic Compounds |
| 07/25/2013 | US20130190258 Compounds for inhibition of cancer cell proliferation |